Sun K H
Zhonghua Wai Ke Za Zhi. 1989 May;27(5):299-300, 318.
Estrogen receptor (ER) of brain tumors was assayed in 45 patients. In this series there were 39 cases contained ER, ranged from 0.7 to 188 fmol/mg protein of tumors (mean: 16.1 fmol/mg). The mean level of ER was 10.3 fmol/mg in 20 cases with meningiomas, 8.4 fmol/mg in 11 cases with gliomas, 51.1 fmol/mg in 5 cases with neurilemmomas, 10.5 fmol/mg in 3 cases with medulloblastomas, 16 fmol/mg in 2 organized hematomas due to ruptured AVM, 5.7 fmol/mg in a chordoma, 3.9 fmol/mg in a metastatic carcinoma from thyroid gland, and 0.8 fmol/mg in a cholesteatoma. The presence of ER in the latter several kinds of brain tumors have not been reported in previous literatures. The ER level of the tumors correlated with histological type of tumors, as well as the sex and age of the patients.
对45例脑肿瘤患者的雌激素受体(ER)进行了检测。在这组病例中,有39例含有ER,肿瘤中ER含量为0.7至188 fmol/mg蛋白质(平均:16.1 fmol/mg)。20例脑膜瘤患者的ER平均水平为10.3 fmol/mg,11例胶质瘤患者为8.4 fmol/mg,5例神经鞘瘤患者为51.1 fmol/mg,3例髓母细胞瘤患者为10.5 fmol/mg,2例因动静脉畸形破裂形成的机化血肿患者为16 fmol/mg,1例脊索瘤患者为5.7 fmol/mg,1例甲状腺转移癌患者为3.9 fmol/mg,1例胆脂瘤患者为0.8 fmol/mg。以往文献中尚未报道后几种脑肿瘤中存在ER。肿瘤的ER水平与肿瘤的组织学类型以及患者的性别和年龄相关。